News

Cactus, Inc. WHD reported fourth-quarter 2025 adjusted earnings of 65 cents per share, which beat the Zacks Consensus Estimate of 58 cents. The bottom line declined from the year-ago quarter’s

Xenon Pharmaceuticals XENE reported a loss of $1.31 per share for the fourth quarter of 2025, wider than the Zacks Consensus Estimate of a loss of $1.20. The company had incurred a loss of 84 cents

SoundHound AI, Inc. SOUN reported fourth-quarter 2025 results, wherein earnings came in line with the Zacks Consensus Estimate, but revenues surpassed the same.

SoundHound AI is gaining momentum as

Globalstar (GSAT) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of $0.01. This compares to a loss of $0.14 per share a year ago. These figures are adjusted

Nomad Foods (NOMD) has been on a downward spiral lately with significant selling pressure. After declining 10.3% over the past four weeks, the stock looks well positioned for a trend reversal as it

Kymera KYMR reported a fourth-quarter 2025 loss of 97 cents per share, wider than the Zacks Consensus Estimate of a loss of 77 cents. In the year-ago quarter, Kymera reported a loss of 88 cents per

AutoZone, Inc. AZO is slated to release second-quarter fiscal 2026 results on March 3, before market open. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings per share (EPS) and

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Amneal Pharmaceuticals (AMRX) reported $814.32 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 11.5%. EPS of $0.21 for the same period compares to

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Gogo (GOGO) reported $230.56 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 67.3%. EPS of -$0.01 for the same period compares to $0.07 a year ago.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

For the quarter ended December 2025, Delek US Holdings (DK) reported revenue of $2.43 billion, up 2.4% over the same period last year. EPS came in at $0.44, compared to -$2.54 in the year-ago

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Marathon Petroleum (MPC) reported $33.42 billion in revenue for the quarter ended December 2025, representing a year-over-year decline of 0.1%. EPS of $4.07 for the same period compares to $0.77 a

ANI Pharmaceuticals (ANIP) reported $247.06 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 29.6%. EPS of $2.33 for the same period compares to

For the quarter ended December 2025, Docebo Inc. (DCBO) reported revenue of $63.04 million, up 10.5% over the same period last year. EPS came in at $0.45, compared to $0.28 in the year-ago quarter.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

BlackRock TCP (TCPC) came out with quarterly earnings of $0.26 per share, missing the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.38 per share a year ago. These